PMD Solutions and its Vision for Respiratory Care
Myles Murray ( PMD Solutions ) and Martin Curley ( HSE ) discuss their partnership and PMD Solutions ’ vision for Respiratory Care .
Respiratory Rate is the earliest sign of deterioration says Myles Murray , CEO at PMD Solutions . The reason for this is that your breathing is driven by how healthy you are . An infection or fluid building up in the lungs from Pneumonia or COVID requires your lungs to work harder in order to stabilise the body .
Respiratory rate is wellestablished globally as the earliest and most sensitive indicator of deterioration , Murray adds . However , the challenge has been to measure this sentinel vital signs accurately .”
Adding to Murray ’ s comments , Martin Curley , Director , Digital Transformation and Open Innovation , at HSE , says that “ there has been very little innovation in actually measuring respiration rate .
It ’ s very subjective . We found that in almost 80 % of the cases , the subjective measurement by the nurse were different . And this isn ’ t because they are bad nurses . It ’ s because it ’ s inherently difficult to measure . So the ability in a general ward to measure respiration rate really is a game-changer .”
PMD Solutions and HSE
Reflecting on the genesis of this partnership , Murray starts off by explaining that RespiraSense was launched as part of the COVID response in Beaumont Hospital . “ Within a few weeks they saw enormous value from the technology , and because of that success , RespiraSense were very kindly introduced to the Digital Transformation team at the HSE .”
Taking just three months to deploy nationally as a de facto standard of care in respiratory compromised patients , Curley reflects on a recent meeting : “ one of the more senior clinical engineers in the network commented at one of our meetings that she was amazed at how fast this could be rolled out . She said “ normally , a new programme like this would take two to three years in the HSE , and it took three months .”
Learn more